Virus Research At Serbia's Institute of Virology

A laboratory technician injects Influenza A (H1N1) virus into a tray of embryonated hens' eggs during vaccine research work at the Torlak Institute of Virology in Belgrade, Serbia, on Tuesday, March 3, 2020. Coronavirus death rates, estimated at around 2%, are higher than the 0.1% for seasonal flu, another lung infection, but far lower than those from severe acute respiratory syndrome, or SARS, the related virus that killed about 9.6% of some 8,000 people infected. Photographer: Oliver Bunic/Bloomberg via Getty Images
A laboratory technician injects Influenza A (H1N1) virus into a tray of embryonated hens' eggs during vaccine research work at the Torlak Institute of Virology in Belgrade, Serbia, on Tuesday, March 3, 2020. Coronavirus death rates, estimated at around 2%, are higher than the 0.1% for seasonal flu, another lung infection, but far lower than those from severe acute respiratory syndrome, or SARS, the related virus that killed about 9.6% of some 8,000 people infected. Photographer: Oliver Bunic/Bloomberg via Getty Images
Virus Research At Serbia's Institute of Virology
LICENTIE KOPEN
Hoe mag ik dit beeld gebruiken?
€ 475,00
EUR

GEGEVENS

Beperkingen:
Neem voor gebruik voor alle commerciële of promotiedoeleinden contact op met uw lokale kantoor.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credits:
Bloomberg / Contributor
Redactioneel nr.:
1205043881
Collectie:
Bloomberg
Gemaakt op:
04 maart 2020
Datum van uploaden:
Soort licentie:
Rights managed
Release-informatie:
Geen release. Meer informatie
Bron:
Bloomberg
Naam materiaal:
SERBIA VACCINE
Max. bestandsgrootte:
4000 x 2889 px (33,87 x 24,46 cm) - 300 dpi - 2 MB